Clin2
NCT07772921Possibly a fitRecruiting

New study medicine for severe asthma

Asthma

Part of Immune system & allergy, Lungs & breathing clinical trials.

This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,100 people
Ages
12 years to 80 years
Study type
Interventional

Who can take part

  • You have had severe asthma for at least 12 months
  • You've had at least 2 asthma attacks in the last year that needed steroids or a hospital visit
  • Your breathing test shows improvement after using a rescue inhaler
  • You are currently using a high-dose inhaled steroid plus another controller medicine
  • You have not used certain other biologic treatments or investigational drugs recently

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06932263Recruiting· Phase 2
Study of a new asthma medicine for uncontrolled asthma

This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.

Bakersfield, California
NCT07869043Recruiting· Phase 3
Study of tilrekimig for people with severe asthma

This study tests an investigational medicine called tilrekimig for people with severe asthma that is not well controlled. The goal is to see if it can reduce asthma attacks and improve breathing.

Pittsburgh, Pennsylvania
NCT06977581Recruiting· Phase 2
Study of PF-07275315 for moderate-to-severe asthma

This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.

Mobile, Alabama
NCT07746687Not yet recruiting· Phase 2
Study of an experimental pill for uncontrolled moderate to severe asthma

This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.

NCT06323213Recruiting· Phase 3
Testing a new asthma medicine for severe asthma

This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.

Shanghai, Shanghai Municipality
NCT06811740Enrolling by invitation
Treating severe asthma by focusing on key health issues

This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.

Beijing, Beijing Municipality

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.